Sodium Hyaluronate

透明质酸钠

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameSodium Hyaluronate
Drug Alias Nameartificial tear玻璃酸钠玻尿酸钠AdantArtz +[57] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyaluronic acid replacements
TargetsHyaluronic acid
Therapy Area/IndicationsNasolabial fold wrinklesCoronavirus Disease 2019 (COVID-19)Ophthalmologic surgical procedures +[25] 
Global Approved IndicationsOphthalmologic surgical proceduresMuscular DiseasesBone Diseases
Approved Indications in ChinaMuscular DiseasesBone Diseases
Original Approved Country/TerritoryN/A
Original Approved Date1987/01/01
Country/TerritoryBelgiumCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesOctober University For Modern Sciences And ArtsInternational Islamic University MalaysiaUniversitas Sriwijaya +[15] 
Inactive CompaniesCellular Biomedicine Group LtdLaboratoires Thea SASChugai Pharmaceutical Co Ltd +[27] 
Active IndicationsNasolabial fold wrinklesCoronavirus Disease 2019 (COVID-19)Ophthalmologic surgical procedures +[15] 
Inactive IndicationsPost-surgical adhesionsAnkle InjuriesBurns +[10] 

Other Information

ATC CodeD03AX05M09AX01R01AX09 +[4] 
Related LinksWikipediaDrugBankKEGG